To develop and produce medical technology instruments for customers all over the world...
New compliance ensures enhanced safety and efficacy for cytogenetic testing in the EU, advancing diagnostic capabilities....
MyopiaX-1 proof-of-concept clinical trial supports MyopiaX’s safety and tolerability profile ...
Designed to treat hip and femur fractures...
The device allows to optimize the contact surface between implant and endplates...
To develop global market for healthcare solutions that utilise NMR and AI technologies...
To predict the likelihood of post-surgery breast cancer recurrence...
More than 400 new jobs for skilled workers from the region...
Nerivio is planned to be launched in the United Kingdom next June...
AI Airlock can enhance the relationship between developers and manufacturers...
